These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36620074)

  • 1. Stimulation of the immune system by a tumor antigen-bearing adenovirus-inspired VLP allows control of melanoma growth.
    Besson S; Boucher E; Laurin D; Manches O; Aspord C; Hannani D; Fender P
    Mol Ther Methods Clin Dev; 2023 Mar; 28():76-89. PubMed ID: 36620074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-Inspired Virus-Like-Particles Displaying Melanoma Tumor Antigen Specifically Target Human DC Subsets and Trigger Antigen-Specific Immune Responses.
    Besson S; Laurin D; Chauvière C; Thépaut M; Kleman JP; Pezet M; Manches O; Fieschi F; Aspord C; Fender P
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization with a versatile adenovirus-inspired multimerization platform.
    Chevillard C; Amen A; Besson S; Hannani D; Bally I; Dettling V; Gout E; Moreau CJ; Buisson M; Gallet S; Fenel D; Vassal-Stermann E; Schoehn G; Poignard P; Dagher MC; Fender P
    Mol Ther; 2022 May; 30(5):1913-1925. PubMed ID: 35151843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model.
    Chu X; Li Y; Long Q; Xia Y; Yao Y; Sun W; Huang W; Yang X; Liu C; Ma Y
    Int J Nanomedicine; 2016; 11():2417-29. PubMed ID: 27313455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VLP-factory™ and ADDomer
    Sari-Ak D; Bufton J; Gupta K; Garzoni F; Fitzgerald D; Schaffitzel C; Berger I
    Curr Protoc; 2021 Mar; 1(3):e55. PubMed ID: 33729713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response.
    Peacey M; Wilson S; Perret R; Ronchese F; Ward VK; Young V; Young SL; Baird MA
    Vaccine; 2008 Oct; 26(42):5334-7. PubMed ID: 18706958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P22 virus-like particles as an effective antigen delivery nanoplatform for cancer immunotherapy.
    Li W; Jing Z; Wang S; Li Q; Xing Y; Shi H; Li S; Hong Z
    Biomaterials; 2021 Apr; 271():120726. PubMed ID: 33636548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial superglue enables easy development of efficient virus-like particle based vaccines.
    Thrane S; Janitzek CM; Matondo S; Resende M; Gustavsson T; de Jongh WA; Clemmensen S; Roeffen W; van de Vegte-Bolmer M; van Gemert GJ; Sauerwein R; Schiller JT; Nielsen MA; Theander TG; Salanti A; Sander AF
    J Nanobiotechnology; 2016 Apr; 14():30. PubMed ID: 27117585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity.
    Villegas-Mendez A; Garin MI; Pineda-Molina E; Veratti E; Bueren JA; Fender P; Lenormand JL
    Mol Ther; 2010 May; 18(5):1046-53. PubMed ID: 20179681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Modular Vaccine Development Platform Based on Sortase-Mediated Site-Specific Tagging of Antigens onto Virus-Like Particles.
    Tang S; Xuan B; Ye X; Huang Z; Qian Z
    Sci Rep; 2016 May; 6():25741. PubMed ID: 27170066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site.
    Lopes A; Feola S; Ligot S; Fusciello M; Vandermeulen G; Préat V; Cerullo V
    J Immunother Cancer; 2019 Jul; 7(1):174. PubMed ID: 31291991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus-like particles access major histocompatibility class I and II antigen presentation pathways in primary dendritic cells.
    Moffat JM; Cheong WS; Villadangos JA; Mintern JD; Netter HJ
    Vaccine; 2013 Apr; 31(18):2310-6. PubMed ID: 23473776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.
    Cabral-Miranda G; Heath MD; Mohsen MO; Gomes AC; Engeroff P; Flaxman A; Leoratti FMS; El-Turabi A; Reyes-Sandoval A; Skinner MA; Kramer MF; Bachmann MF
    Vaccines (Basel); 2017 May; 5(2):. PubMed ID: 28468322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus like particles as a platform for cancer vaccine development.
    Ong HK; Tan WS; Ho KL
    PeerJ; 2017; 5():e4053. PubMed ID: 29158984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs.
    McGregor J; Hardy JM; Lay CS; Boo I; Piontek M; Suckow M; Coulibaly F; Poumbourios P; Center RJ; Drummer HE
    J Virol; 2022 Mar; 96(5):e0167521. PubMed ID: 34986001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial superglue generates a full-length circumsporozoite protein virus-like particle vaccine capable of inducing high and durable antibody responses.
    Janitzek CM; Matondo S; Thrane S; Nielsen MA; Kavishe R; Mwakalinga SB; Theander TG; Salanti A; Sander AF
    Malar J; 2016 Nov; 15(1):545. PubMed ID: 27825348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Norovirus-VLPs expressing pre-erythrocytic malaria antigens induce functional immunity against sporozoite infection.
    Schneider CG; Fey J; Zou X; Gerbasi V; Savransky T; Batt C; Bergmann-Leitner E; Angov E
    Vaccine; 2022 Jul; 40(31):4270-4280. PubMed ID: 35697572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control.
    Tondini E; Arakelian T; Oosterhuis K; Camps M; van Duikeren S; Han W; Arens R; Zondag G; van Bergen J; Ossendorp F
    Oncoimmunology; 2019; 8(11):1652539. PubMed ID: 31646082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.